NVAX
Novavax, Inc.
NASDAQ · Healthcare · Biotechnology · US
$10.22
−1.16%Margins
Gross margin
77.9%
EBITDA margin
-48.9%
EBIT margin
-54.9%
Net margin
-59.9%
FCF margin
-10.5%
129.9%
Return on equity
-25.9%
Return on assets
-216.7%
Return on invested capital
0.41x
Asset turnover
-$39.5M
Cash from operations
$4.36
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026